Publications by authors named "Jing-cui Peng"

Article Synopsis
  • - For patients with EGFR-mutant advanced non-small cell lung cancer (NSCLC), first-line treatments typically include drugs like gefitinib and osimertinib, but drug resistance, often due to the T790M mutation, is common, leading to a need for second-line options.
  • - A recent case study focused on a 35-year-old pregnant woman with advanced EGFR-mutant NSCLC who developed resistance to almonertinib, revealing an EML4-ALK fusion mutation as a potential resistance mechanism through next-generation sequencing.
  • - The case contributes to the limited research on ALK rearrangement in EGFR-TKI resistance and highlights the potential of combining almonertinib with crizotin
View Article and Find Full Text PDF

Objective: This study was to investigate the efficacy and safety of gefitinib plus anlotinib for patients with EGFR positive advanced non-small cell lung cancer (NSCLC) in a first-line setting.

Methods: A total of 36 patients with previously-untreated EGFR positive advanced NSCLC were included in this study retrospectively. All patients were administered with gefitinib plus anlotinib combination therapy.

View Article and Find Full Text PDF

In the present study, the therapeutic effects and the underlying molecular mechanisms of microRNA (miR)‑145 were investigated in non‑small cell lung cancer (NSCLC) cells. Reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) was performed to examine miR‑145 expression. An MTT assay and flow cytometry were used to investigate cell proliferation and apoptosis, respectively.

View Article and Find Full Text PDF

The present study determined the anticancer activity and its mechanism of microRNA‑133b on cell proliferation of cisplatin-induced non-small cell lung cancer cells. The expression of microRNA-133b cisplatin‑induced non-small cell lung cancer (NSCLC) tissue was lower than that of para-carcinoma tissue in patients. Overall survival of higher expression in cisplatin-induced NSCLC patients was higher than that of lower expression in cisplatin‑induced NSCLC patients.

View Article and Find Full Text PDF

In this paper, the theoretical model of recombination was presented and the effect of temperature and applied voltage on the recombination efficiency was investigated in double layer organic light-emitting diodes: ITO/PPV/PBD/Ca. At lower applied voltage, two peaks have been observed in the curve of recombination efficiency vs. temperature.

View Article and Find Full Text PDF

The photonic band structures and the effect of defect states on photonic band gap in a comblike waveguide geometry which were made of dangling side branches grafted periodically along an infinite monomode waveguide were investigated in this paper. It was discovered that the photonic forbidden bands originates from both the periodicity of the system and the resonance states of the grafted branches. By removing or inserting some defect branches in the star waveguide of finite number of grafted branches, the localized states appear in the transmission spectrum as very narrow peaks.

View Article and Find Full Text PDF

The PL and EL spectra of 5,6,11,12-tetraphenyl-tetracene doped 8-hydroxyquinoline are measured. It is found that Alq is host emitter when dopant concentration is low, and a discrete level is introduced by doping Rubrene (guest emitter) in Alq energy gap. As increasing Rubrene concentration, Rubrene is host emitter but Alq becomes guest emitter.

View Article and Find Full Text PDF

Based on the physical processes of carriers transport and recombination, a multi-barriers model for carriers transport and recombination in bilayer organic devices is present. The influences of applied bias and thin films (transport layers) barriers on carriers recombination and its efficiency are calculated and discussed. In bilayer organic devices the charge density inside the sample is controlled by interfacial charge accuulation.

View Article and Find Full Text PDF